Nusano News
Nusano to Participate in the B. Riley Securities Radiopharma Investor Conference
VALENCIA, Calif. – February 26, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will participate in a...
Video Replay: Unlocking the Next $20-30B Market Opportunity in Oncology: Radioisotope Production & Applications
With many now expecting radiopharamaceuticals to grow into a $20-30 billion market, investors are increasingly looking...
Nusano to Participate in Isotope and Radiopharmaceutical Conferences
Nusano, Inc., a company working to stabilize and enable the production of cancer-fighting radioisotopes, is participating in two conferences in July 2023.
Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
Nusano and PharmaLogic will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.
Industry News
U.S. investing in domestic isotope supply
Department of Energy Secretary Jennifer Granholm breaks ground on facility to provide radioisotopes vital to national security, research and health care.
University of Missouri responds to global radioisotope shortage
An unplanned production outage in Europe poses a threat to radioisotope supplies worldwide.
Reuters: EU may face shortage of key materials for diagnostics, cancer treatments
European officials are warning of a potential shortage of medical radioisotopes needed for advanced health care and imaging procedures.
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates